1. 481PUpdated survival outcomes of the phase II study of low starting dose of afatinib as first-line treatment in patients with EGFR mutation-positive non-small cell lung cancer (KTORG1402). (24th November 2019) Authors: Yokoyama, T; Yoshioka, H; Fujimoto, D; Demura, Y; Hirano, K; Kawai, T; Kagami, R; Ishida, T; Tomii, K; Akai, M; Hirabayashi, M; Nishimura, T; Nakahara, Y; Kim, Y H; Yoshimura, K; Hirai, T Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Prediction of clinical outcomes in patients with coronavirus disease 2019 using high-sensitive troponin I and N-terminal pro-B-type natriuretic peptide. (3rd October 2022) Authors: Sano, M; Toyota, T; Morimoto, T; Okada, T; Sasaki, Y; Taniguchi, T; Kim, K; Kobori, A; Ehara, N; Kinoshita, M; Doi, A; Tomii, K; Kihara, Y; Furukawa, Y Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗